PDGFR Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 5013 | AC 710 |
| Potent and selective PDGFR family inhibitor | |
| 4274 | AP 24534 |
| Potent multi-kinase and pan-Bcr-Abl inhibitor | |
| 7454 | Cediranib |
| Potent inhibitor of VEGFR, PDGFR and FGFR | |
| 5993 | CP 673451 |
| Potent and selective PDGFR inhibitor | |
| 5906 | Imatinib mesylate |
| PDGFR inhibitor; also inhibits v-Abl tyrosine kinase and c-kit | |
| 6976 | JNJ 10198409 |
| Potent PDGFRα and PDGFRβ inhibitor; also inhibits c-Abl, Lck, c-Src and Fyn kinases | |
| 5260 | KG 5 |
| PDGFRβ, B-Raf, c-Raf, FLT3 and KIT inhibitor; antiangiogenic | |
| 7743 | Linifanib |
| Potent inhibitor of PDGFRβ, KDR, FLT3 and CSF-1R | |
| 7705 | Masitinib |
| PDGFR inhibitor | |
| 7049 | Nintedanib |
| Potent VEGFR, PDGFR and FGFR inhibitor | |
| 3785 | PD 166285 dihydrochloride |
| PDGFRβ, FGFR and Src inhibitor; also inhibits Wee1 | |
| 6814 | Sorafenib |
| PDGFR-β inhibitor; also inhibits Raf-1, VEGFR-2, VEGFR-3, Flt-3 and cKIT | |
| 3304 | SU 16f |
| Potent and selective PDGFRβ inhibitor | |
| 3768 | Sunitinib malate |
| Potent VEGFR, PDGFRβ and KIT inhibitor |
Angiogenesis in Cancer Life Science Poster
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDF